{
    "clinical_study": {
        "@rank": "23509", 
        "acronym": "NSnatbio", 
        "arm_group": [
            {
                "arm_group_label": "Netherton syndrome", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients with Netherton syndrome"
            }, 
            {
                "arm_group_label": "Healthy controls", 
                "arm_group_type": "Active Comparator", 
                "description": "healthy controls"
            }
        ], 
        "brief_summary": {
            "textblock": "This study aims at studying the natural history of Netherton syndrome (NS), to identify the\n      consequences of LEKTI deficiency on the immune system and to characterize new molecular\n      mechanisms involved in the disease."
        }, 
        "brief_title": "Natural History and Biological Study of Netherton Syndrome", 
        "completion_date": {
            "#text": "November 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Netherton Syndrome", 
            "Healthy"
        ], 
        "condition_browse": {
            "mesh_term": "Netherton Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult or child (no age limit)\n\n          -  Confirmed diagnosis of Netherton syndrome\n\n          -  Signed informed consent form for the patient or his legal representative\n\n        Exclusion Criteria:\n\n          -  Bleeding disorder precluding skin biopsy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02081313", 
            "org_study_id": "C12-56", 
            "secondary_id": "2013-A00275-40"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Netherton syndrome", 
                    "Healthy controls"
                ], 
                "intervention_name": "Biopsy", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Netherton syndrome", 
                    "Healthy controls"
                ], 
                "intervention_name": "Blood sample", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Netherton syndrome", 
            "Immune system", 
            "Skin barrier"
        ], 
        "lastchanged_date": "March 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75015"
                }, 
                "name": "Imagine Institute for genetic diseases"
            }, 
            "investigator": {
                "last_name": "Alain Hovnanian, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Syndrome de Netherton : Aspects Cliniques, Physiopathologiques et Identification de Cibles th\u00e9rapeutiques", 
        "overall_contact": {
            "email": "alain.hovnanian@inserm.fr", 
            "last_name": "Alain Hovnanian, MD, PhD", 
            "phone": "33142754289"
        }, 
        "overall_contact_backup": {
            "email": "laetitia.furio@inserm.fr", 
            "last_name": "Laetitia Furio, PhD", 
            "phone": "33142754368"
        }, 
        "overall_official": {
            "affiliation": "INSERM U1163", 
            "last_name": "Alain Hovnanian, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Measurement of seric cytokines levels", 
            "safety_issue": "No", 
            "time_frame": "3 months after patient recruitment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02081313"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Pattern of skin abnormalities", 
            "safety_issue": "No", 
            "time_frame": "3 months after patient recruitment"
        }, 
        "source": "Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale, France", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale, France", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}